Adam Friedman, MD, FAAD
Associate Professor of Dermatology
Residency Program Director
Director of Translational Research
Director of Supportive Oncodermatology
Department of Dermatology
George Washington School of Medicine and Health Sciences
Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction. He holds several patents derived from these investigations, and has published over 90 papers/chapters and two textbooks on both his research as well as a variety of clinical areas in dermatology with an emphasis on emerging medical therapies. Dr. Friedman has presented his research in both national and international forums, and has received awards from multiple organizations such as the American Academy of Dermatology and American Society for Dermatologic Surgery.